RTOG Address
Search  
HomeMember InfoProtocolsResearcherMeetingsVisitorsFAQSite Map
RTOG  Data  Collection  and  Web  Registration  Information

RTOG Web-Based Registration and Data Collection Manual

FORMS AVAILABLE FOR ELECTRONIC DATA SUBMISSION (Centers enrolling patients through RTOG are required to submit RTOG study data via web-entry for the following studies/forms.)

  1. 0012 Phase II Rectal Follow-up (F1)
  2. 0019 Phase II Prostate Implant Follow-up (F1)
  3. 0022 Head and Neck IMRT Follow-up (F1)
  4. 0024 Phase II Post-Op Head & Neck Follow-up (F1)
  5. 0113 Esophagus Follow-up (F1)
  6. 0114 Gastric Follow-up (F1)
  7. 0116 Phase II Cervix Follow-up (F1)
  8. 0126 Prostate Follow-up (F1)
  9. 0128 Cervix - Follow-up (F1)
  10. 0129 Head and Neck Follow-up (F1)
  11. 0131 Phase II Trial of Pre-Irradiation and Concurrent Temozolomide Follow-up (F1)
  12. 0132 Gleevec (STI-571)/Gist Follow-up (F1)
  13. 0212 Phase II/III Lung Follow-up (F1)
  14. 0214 Lung Prophylactic Cranial RT Follow-up (F1)
  15. 0225 Phase II Nasopharyngeal IMRT/Chemotherapy Follow-up (F1)
  16. 0227 Phase I/II CNS Lymphoma Follow-up (F1)
  17. 0229 Phase II Lung Follow-up (F1)
  18. 0232 Phase III Prostate Initial Evaluation (I1), Initial Follow-up for Acute RT (FS), F1 Follow-up Late RT, The Expanded Prostate Cancer Index Composite (EPIC) (FA), Utilization of Sexual Medications/Devices (SA), AUA Patient Urinary Symptom Questionnaire (PQ)
  19. 0233 Bladder/Chemotherapy + RT F1 Follow-up
  20. 0234 Phase II Head & Neck Cancer Follow-up Form (F1/AE)
  21. 0244 Head & Neck Phase II Salivary Follow-up (F1)
  22. 0246 Esophagus Follow-up (F1)
  23. 0247 Rectal Follow-up (F1)
  24. 0319 Breast Follow-up (F1)
  25. 0320 Phase III Brain Follow-up (F1)
  26. 0321 Phase II Prostate Follow-up (F1)
  27. 0324 Phase II Lung Follow-up (F1)
  28. 0415 Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1), Adverse Event Evaluation (AE), Hopkins Symptom Checklist-25 (HP), The Expanded Prostate Cancer Index Composite (EPIC) (FA), Utilization of Sexual Medications/Devices (SA)
  29. 0417 Cervix Follow-up (F1), Initial Evaluation (I1), Radiotherapy (T1)
  30. 0418 Phase II IMRT Radiotherapy Form(T1), Phase II Cx/Endo Follow-up (F1), Initial Evaluation (I1), Treatment Summary (TF), Adverse Event Evaluation (AE)
  31. 0424 Phase II Brain Follow-up (F1)
  32. 0436 Phase III Esophagus Initial Evaluation (I1), Radiotherapy (T1), Post Treatment Response (F2), Followup (F1), Treatment Summary Form (TF )
  33. 0438 Phase I Liver Follow-up (F1)
  34. 0513 Phase I/II GBM Initial Evaluation(I1), Follow-up Form (F1), Adverse Event Evaluation (AE)
  35. 0515 NSCLC Follow up (F1)
  36. 0517 Palliation Bone Mets Initial Evaluation Form (I1) , Follow up (F1), Treatment Summary Form (TF )
  37. 0518 Phase III Prevent Osteo Initial Evaluation(I1), Follow-up (F1), Treatment Summary Form (TF), Radiotherapy Form (T1)
  38. 0521 Radiotherapy Form (T1) ,Initial Follow-up (F0), Interim Follow Up (FS), Follow-up (F1), Initial Evaluation (I1), Treatment Summary Form (TF), Adverse Event Evaluation (AE)
  39. 0522 Advanced H & N Follow-up (F1), Radiotherapy Form (T1), Initial Evaluation (I1), Surgery Form (S1)
  40. 0524 Chemo/XRT for Non-cystectomy Bladder Cancer Initial Evaluation Form (I1)
  41. 0525 Brain GBM all forms
  42. 0526 Phase II Prostate Brachy Initial Evaluation (I1), Followup (F1), Radiotherapy(T1)
  43. 0529 Phase II Anal Canal Follow-up (F1), Initial Evaluation (I1), Post Treatment Response (F2), Radiotherapy (T1)
  44. 0534 Interim Follow-up Form (F0),Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1),EPIC (FA), Neurocognitive Evaluation Summary Form(CS), Utilization of Sexual Meds/Devices (SA),American Urological Association Symptom Index (AUA SI)(PQ), HSCL-25 (HP)
  45. 0537 Phase II/III Electroacustimulation/Pilocarpine Follow-up (F1), Initial Evaluation (I1), Treatment Summary Form (TF), XeQOLS (QF), UWHNSS (HP)
  46. 0539 Phase II Meningioma Central Radiology Form (SR), Initial Evaluation (I1), Radiotherapy Form(T1)
  47. 0611 GBM VEGF/MMP Follow-up (F1), Initial Evaluation (I1)
  48. 0614 Phase III Memantine/Placebo/WBRT Initial Evaluation (I1), Follow-up (F1), Treatment Summary (TF), Radiotherapy Form(T1)
  49. 0615 Phase II Nasopharyngeal Radiotherapy Form (T1), Initial Evaluation (I1)
  50. 0617 Phase III NSCLC Initial Evaluation (I1),Treatment Summary Form (TF), Radiotherapy Form (T1),Treatment Summary Form (TS),Treatment Summary Form (SF), Follow-up (F1)
  51. 0618 Phase II SBRT Initial Evaluation (I1), Radiotherapy Form (T1), Adjuvant Chemo Question (TF), Followup Form (F1)
  52. 0619 Phase II High-Risk Follow-up (F1), Post-Op H & N Initial Follow-up Form (F0), Initial Evaluation (I1), Radiotherapy Form (T1), Treatment Form (TF)
  53. 0621 Phase II Prostate Initial Evaluation (I1), Initial Follow Up Form (F0), Follow Up Form (F1), Phase II Prostate Radiotherapy (T1), Treatment Summary (TF)
  54. 0622 Phase II Prostate Samarium Initial Evaluation (I1), Treatment Summary Form (TF), Follow Up Form (F1)
  55. 0623 Phase II SCLC Initial Evaluation (I1), Radiotherapy Form (T1)
  56. 0627 Phase II GBM Follow-up (F1), Initial Evaluation (I1)
  57. 0630 Phase II Sarcoma Initial Evaluation (I1), Radiotherapy(T1), Surgery Form (S1) , Wound Assessment Form (P0), Treatment Summary Form (TF), Followup (F1)
  58. 0631 Phase II/III Spine Mets Follow-up (F1), Radiation Therapy Form (T1), Adverse Event Evaluation Form (AE), Initial Evaluation Form (I1)
  59. 0712 Phase II Bladder Initial Evaluation (I1), Induction Treatment Summary Form (TF), Follow-up (F1), Urodynamics Form (UR), Post Treatment Evaluation (F0), Adjuvant Treatment Summary(AF), Surgery (S1), Consolidation Radiotherapy Treatment (F4), Induction Radiotherapy Treatment (T1), Consolidation Treatment Summary Form (SF)
  60. 0724Phase III Cervix Initial Evaluation (I1), Radiotherapy(T1), Concurrent Systemic Treatment Summary (TF), Adjuvant Systemic Treatment Summary (SF), Followup (F1), Demographic Form (A5), Quality of Life Form (QL)
  61. 0813 Phase I/II SBRT Initial Evaluation Form (I1), Follow Up Form (F1), Radiotherapy Form (T1)
  62. 0815 Phase III Prostate Initial Evaluation Form (I1), Demographic Data Form (A5), Radiation Therapy Form (T1), Initial Follow-up Form (F0), EPIC (FA), PROMIS (HP), PSQI/GLTEQ (QL)
  63. 0822 Phase II Rectal Initial Evaluation Form(I1), Follow Up Form(F1), Surgery Form (S1), Post-op Treatment Summary Form (SF), Pre-op Treatment Summary Form (TF), Radiotherapy Form(T1)
  64. 0825 Phase III GBM Neurocognitive Evaluation Summary Form (CS), Salvage Treatment Summary (SF), Followup (F1), Initial Evaluation Form (I1),Treatment Summary Form (TF), Pre-Randomization Pathology (P4), Code Breaking (CX), Salvage Guideline Questionnaire (SX), Radiotherapy (T1), Radiology Review (SR)
  65. 0831 Phase III Tadalafil/Placebo Prostate Demographic Data Form (A5), Initial Evaluation Form (I1), Radiotherapy Form (T1), Treatment Summary Form (TF), Follow-Up Form (F1), IIEF (patient) (QF), LMAT (patient) (PF), LMAT (spouse/partner) (PQ), EPIC (use of Erectile Aids) (FA), SAQ (patient) (SA)
  66. 0837 Phase II GBM Demographic Data Form (A5), Initial Evaluation Form (I1), Treatment Summary Form (TF), Followup Form (F1), Specimen Transmittal Form (SF), Radiotherapy Form (T1), Radiology Review Form (SR)
  67. 0841 Screening for Depression Initial Evaluation (I1), HSCL-25 Form (HP), PHQ-9 (PHQ-2) (PQ)Form, HSQ Form (QL)
  68. 0848 Phase III Pancreas Demographic Data Form (A5), Initial Evaluation Form (I1), Surgery Form (S1), Radiotherapy Form (T1), Systemic Treatment Summary Form (TF), Post ARM 1 or 2 Tumor Status Form (F3), AT Additional Systemic Treatment Summary Form (AT), Concurrent Systemic Treatment Summary Form (SF), Follow Up Form (F1), FACIT - Fatigue (FA), PROMIS Fatigue Short Form-1 (PR)
  69. 8531 Phase III Prostate Follow-up (F1)
  70. 0915 phase II SBRT Demographic Data (A5), Initial Evaluation (I1), Follow-up (F1), Radiation Therapy Form (T1)
  71. 0920 Phase III Post-Op Advanced H & N Demographic Data Form (A5), Initial Evaluation Form (I1), Treatment Form (TF), Initial Follow-up Form (F0), Follow-up Form (F1), Radiation Therapy Form (T1)
  72. 0921 Phase II Endometrial Demographic Data Form (A5), Initial Evaluation Form (I1), Treatment Summary Form(TF), Systemic Treatment Summary Form(SF), Follow-up Form (F1), Radiotherapy Form (T1)
  73. 0926 Phase II Bladder Demographic Data Form(A5), Initial Evaluation Form (I1), Post Chemoradiation Evaluation Form(F0), Chemotherapy Treatment Summary Form (TF), Surgery Form(S1), Radiotherapy Form (T1), Follow-up (F1)
  74. 9202 Phase III Prostate Follow-up (F1)
  75. 9111 Larynx (F1)
  76. 9406 Prostate Follow-up (F1)
  77. 9408 Prostate Follow-up (F1)
  78. 9413 Prostate Follow-up (F1)
  79. 9501 Post-Op Follow-up (F1)
  80. 9512 T2 Vocal Cord Follow-up (F1)
  81. 9601 Prostate Follow-up (F1)
  82. 9704 Pancreas Follow-up (F1)
  83. 9703 Advanced H & N Follow-up (F1)
  84. 9804 DCIS Breast Follow-up (F1)
  85. 9811 Anal Canal Follow-up (F1)
  86. 9902 Prostate Follow-up Form (F1)
  87. 9903 Head and Neck Follow-up Form (F1)
  88. 9904 Follow-up Form (F1)
  89. 9910 Prostate Follow-up (F1)

WEB REGISTRATION & DATA SUBMISSION LINKS

PRACTICE
RTOG - Pilot (Study - 9998)

ACTIVE STUDIES
RTOG Protocols


SYSTEM REQUIREMENTS FOR WEB REGISTRATION

In the near future RTOG will embark on an initiative to activate Web registration for a number of its studies. In preparation for this event, we would like to provide some vital information which will assist you to determine if your site is appropriately equipped to participate in this new Web service.

In order to use the Web Registration module successfully, all participating sites must meet the minimum system requirements as indicated below:

  • Pentium III or greater processor with minimum 128 MB RAM.
  • Microsoft Windows 98, 2000 or XP.
  • Free Hard Drive Storage space 100 MB.
  • Video card with 2 MB of RAM for minimum 16 bit (High Color) display
  • Internet Explorer version 6.0 or above installed.
  • Netscape Navigator 7.1.

Attached you will find two (2) documents that deal with the Internet Explorer and Netscape Navigator browser settings that have to be changed to meet our requirements.

Please take this opportunity to contact your local IT support staff to resolve any problems that may relate your ability to utilize this service.

  1. IE Browser Settings
  2. Navigator Browser Settings

If you would like to utilize Web Registration site to register a patient and have not been assigned a user name and password from RTOG Headquarters, please access the Password Authorization Form from the link provided. You must fill this form out completely and have it signed by the member institution Principal Investigator. All forms should be faxed to RTOG Headquarters at (215) 928-0153.

  1. RTOG Password Authorization Form
OPEN STUDIES FOR WEB REGISTRATION
  1. 0227 - PHASE I/II
  2. 0232 - PROSTATE: BRACHYTHERAPY +/- EXT. BEAM RT
  3. 0235 - NSCLC PET STAGING AND ASSESSMENT (ACRIN 6668)
  4. 0436 - PHASE III ESOPHAGUS
  5. 0438 - EXTRACRANIAL 3DCRT UNRESECTABLE LIVER METASTASES
  6. 0514 - HEAD AND NECK TISSUE BANK
  7. 0517 - PALLIATION BONE METS
  8. 0524 - BLADDER CANCER: SURGERY+PACLITAXEL, TRASTUZUMAB, AND RT
  9. 0526 - PHASE II PROSTATE/BRACHY
  10. 0537 - PHASE II/III ELECTROACUSTIMULATION/PILOCARPINE
  11. 0534 - PHASE III PROSTATE
  12. 0539 - PHASE II MENINGIOMA
  13. 0611 - URINARY VEGF & MMP LEVELS POST-RT IN PTS WITH GBM
  14. 0612 - PROSTATE DNA MICROARRAY
  15. 0617 - PHASE III NSCLC Radiotherapy
  16. 0619 - Phase II High-Risk Post-Op H & N
  17. 0621 - Phase II Prostate Radiotherapy
  18. 0622 - Phase II Prostate Samarium
  19. 0627 - PHASE II GBM
  20. 0630 - PHASE II SARCOMA
  21. 0631 - PHASE II/III SPINE METS
  22. 0724 - PHASE III CERVIX
  23. 0815 - PHASE III Intermed Risk Prostate
  24. 0825 - 0825 PHASE III GBM
  25. 0831 - 0831 Phase III TADALAFIl/PLACEBO PROSTATE
  26. 0837 - 0837 Phase II GBM
  27. 0848 - 0848 PHASE III PANCREAS
  28. 0915 - 0915 PHASE II SBRT
  29. 0920 - 0920 PHASE III POST-OP ADVANCED H & N
  30. 0921 - 0921 PHASE II ENDOMENTRIAL
  31. 0926 - 0926 PHASE II BLADDER